Structure-based design of I-BET778: a BD1 selective BET inhibitor

William Kerr, Christopher Wellaway

Research output: Contribution to conferenceSpeech

Conference

Conference4th GSK/University of Strathclyde MPhil/PhD Symposium
CountryUnited Kingdom
CityStevenage
Period23/07/1423/07/14

Keywords

  • structure based design
  • BET inhibitors
  • bromodomain
  • extra-terminal proteins

Cite this

Kerr, W., & Wellaway, C. (2014). Structure-based design of I-BET778: a BD1 selective BET inhibitor. 4th GSK/University of Strathclyde MPhil/PhD Symposium, Stevenage, United Kingdom.
Kerr, William ; Wellaway, Christopher. / Structure-based design of I-BET778 : a BD1 selective BET inhibitor. 4th GSK/University of Strathclyde MPhil/PhD Symposium, Stevenage, United Kingdom.
@conference{c80cee22827f472a9866cff3ff4eb4a9,
title = "Structure-based design of I-BET778: a BD1 selective BET inhibitor",
keywords = "structure based design, BET inhibitors, bromodomain, extra-terminal proteins",
author = "William Kerr and Christopher Wellaway",
year = "2014",
month = "7",
day = "23",
language = "English",
note = "4th GSK/University of Strathclyde MPhil/PhD Symposium ; Conference date: 23-07-2014 Through 23-07-2014",

}

Kerr, W & Wellaway, C 2014, 'Structure-based design of I-BET778: a BD1 selective BET inhibitor' 4th GSK/University of Strathclyde MPhil/PhD Symposium, Stevenage, United Kingdom, 23/07/14 - 23/07/14, .

Structure-based design of I-BET778 : a BD1 selective BET inhibitor. / Kerr, William; Wellaway, Christopher.

2014. 4th GSK/University of Strathclyde MPhil/PhD Symposium, Stevenage, United Kingdom.

Research output: Contribution to conferenceSpeech

TY - CONF

T1 - Structure-based design of I-BET778

T2 - a BD1 selective BET inhibitor

AU - Kerr, William

AU - Wellaway, Christopher

PY - 2014/7/23

Y1 - 2014/7/23

KW - structure based design

KW - BET inhibitors

KW - bromodomain

KW - extra-terminal proteins

UR - http://spider.science.strath.ac.uk/gsk/

M3 - Speech

ER -

Kerr W, Wellaway C. Structure-based design of I-BET778: a BD1 selective BET inhibitor. 2014. 4th GSK/University of Strathclyde MPhil/PhD Symposium, Stevenage, United Kingdom.